Ruth W Mwangi
Overview
Explore the profile of Ruth W Mwangi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuol P, Wambu P, Mwangi R, Matui B, Kiprop A, Sokoto K, et al.
Ann Med Surg (Lond)
. 2024 Dec;
86(12):6913-6915.
PMID: 39649911
No abstract available.
2.
Macharia J, Varjas T, Mwangi R, Kaposztas Z, Rozmann N, Pinter M, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894369
Colon tumors have a very complicated and poorly understood pathogenesis. Plant-based organic compounds might provide a novel source for cancer treatment with a sufficient novel mode of action. The objective...
3.
Macharia J, Mwangi R, Szabo I, Zand A, Kaposztas Z, Varjas T, et al.
Biomed Pharmacother
. 2023 Aug;
166:115325.
PMID: 37586118
The evaluation of natural biomass sources is a promising strategy in accelerating the development of novel anti-cancer medications. Our study aimed to evaluate the activity of W. ugandensis ethanolic roots...
4.
Macharia J, Gakenye G, Rozmann N, Onchonga D, Mwangi R, Kaposztas Z, et al.
Sci Rep
. 2022 Dec;
12(1):22262.
PMID: 36564451
The development of effective, safe, and acceptable vaccines is a long process. COVID-19 vaccine hesitancy continues to elicit mixed reactions among different quarters despite numerous evidence of their effectiveness. This...
5.
Macharia J, Zhang L, Mwangi R, Rozmann N, Kaposztas Z, Varjas T, et al.
Cancer Cell Int
. 2022 Dec;
22(1):379.
PMID: 36457023
After cardiovascular diseases, cancer is the second main cause of death globally. Mushrooms have been demonstrated to contain amalgamation with properties capable of inhibiting carcinogenesis and microbial growth, principally secondary...
6.
Macharia J, Mwangi R, Rozmann N, Zsolt K, Varjas T, Uchechukwu P, et al.
Biomed Pharmacother
. 2022 Jul;
153:113383.
PMID: 35820316
Development and identification of molecular compounds capable of killing or inhibiting transformed cells promoting carcinogenesis without inducing toxic effects to the normal cells are of utmost significance. A systematic review...
7.
Mwangi R, Macharia J, Wagara I, Bence R
Biomed Pharmacother
. 2022 Jan;
147:112621.
PMID: 35026489
Mushroom consumption has grown extraordinarily owing to their high nutritional value, desirable taste, and aroma. Mushrooms continue generating lots of interest chiefly in their consumption as food, as a cure...
8.
Mwangi R, Macharia J, Wagara I, Bence R
Biomed Pharmacother
. 2021 Oct;
144:112240.
PMID: 34601194
Medicinal plant species contain vast and unexploited riches of chemical substances with high medical potential making these plant species valuable as biomedicine sources. Cassia fistula L is an important medicinal...